Description

Humana’s 600,000-Member Reset — Can It Restore 3% Medicare Advantage Margins?

Humana, Inc. reported performance in line with expectations for the first half of 2026, maintaining positive momentum across key operational and financial metrics. The company continues to focus its strategic initiatives around four primary business drivers: enhancing product and customer experience, advancing clinical excellence, improving operational efficiency, and optimizing capital allocation, particularly through growth in Medicaid and its CenterWell platform. Membership growth in 2026 remains on track, supporting Humana’s growth ambitions. The company emphasized its 2027 Medicare Advantage (MA) bidding strategy, which aims to achieve meaningful margin expansion that contributes to its longer-term target of returning to a sustainable pretax margin of at least 3% by 2028. Significant progress is expected in 2027 through adjustments to plan mixes, targeted plan exits (affecting approximately 600,000 members), and ongoing clinical and operational improvements. Humana highlighted advancements in clinical performance, particularly in its Stars quality measures which influence Medicare bonus payments.